Avrobio Inc reported 29.42M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Akebia Therapeutics AKBA:US $ 120.19M 5.57M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Applied Genetic Technologies AGTC:US $ 13.58M 4.86M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Epizyme EPZM:US $ 59.62M 3.25M
Gilead Sciences GILD:US $ 6393M 89M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Karyopharm Therapeutics KPTI:US $ 82.26M 2.95M
Macrogenics MGNX:US $ 77.74M 5.36M
Pfizer PFE:US $ 15788M 3271M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Takeda 4502:JP 874.91B 90.1B